GRPEL1
GrpE protein homolog 1, mitochondrial
Also known as: FLJ25609, GrpE, GRPE1_HUMAN, hMGE
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HAV7
- Gene
- GRPEL1
- Ensembl
- ENSG00000109519
- Chromosome
- 4
- Canonical length
- 217 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Mitochondria
OverviewNCBI Gene
Enables identical protein binding activity and unfolded protein binding activity. Predicted to be involved in protein import into mitochondrial matrix. Located in mitochondrial matrix and nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
217 residues, UniProt reviewed canonical sequence.
>Q9HAV7|GRPEL1
1 MAAQCVRLAR RSLPALALSL RPSPRLLCTA TKQKNSGQNL EEDMGQSEQK ADPPATEKTL
61 LEEKVKLEEQ LKETVEKYKR ALADTENLRQ RSQKLVEEAK LYGIQAFCKD LLEVADVLEK
121 ATQCVPKEEI KDDNPHLKNL YEGLVMTEVQ IQKVFTKHGL LKLNPVGAKF DPYEHEALFH
181 TPVEGKEPGT VALVSKVGYK LHGRTLRPAL VGVVKEALocalizationUniProt · AlphaFold · HPA
Whether an antibody against GRPEL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 36 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 36 nTPM
- liver: 29 nTPM
- skeletal muscle: 27 nTPM
- tongue: 26 nTPM
- bone marrow: 22 nTPM
- heart muscle: 22 nTPM
Single-cell type
- esophageal apical cells: 279 nCPM
- oocytes: 230 nCPM
- esophageal suprabasal cells: 171 nCPM
- esophageal basal cells: 149 nCPM
- hepatocytes: 126 nCPM
- late spermatids: 125 nCPM
Immune cell
- eosinophil: 39 nTPM
- myeloid DC: 35 nTPM
- MAIT T-cell: 30 nTPM
- naive CD4 T-cell: 30 nTPM
- intermediate monocyte: 27 nTPM
- total PBMC: 26 nTPM
Brain region
- white matter: 11 nTPM
- choroid plexus: 11 nTPM
- pons: 10 nTPM
- cerebellum: 9.6 nTPM
- spinal cord: 9.3 nTPM
- thalamus: 9.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.78
- gnomAD pLI
- 0.14
- gnomAD missense Z
- -0.01
- DepMap mean gene effect
- -1.35
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- adenyl-nucleotide exchange factor activity
- identical protein binding
- protein homodimerization activity
- protein-folding chaperone binding
- unfolded protein binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GRPEL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GRPEL1 as an antibody target. Whether an autoantibody or antibody against GRPEL1 could matter depends on whether native GRPEL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GRPEL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GRPEL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...